Literature DB >> 9593452

Inhibition of HIV-1 replication by an aqueous extract of Spirulina platensis (Arthrospira platensis).

S Ayehunie1, A Belay, T W Baba, R M Ruprecht.   

Abstract

An aqueous extract of the blue-green filamentous algae Arthrospira platensis (previously called Spirulina platensis) inhibited HIV-1 replication in human T-cell lines, peripheral blood mononuclear cells (PBMC), and Langerhans cells (LC). Extract concentrations ranging between 0.3 and 1.2 microg/ml reduced viral production by approximately 50% (50% effective concentration [EC50]) in PBMCs. The 50% inhibitory concentration (IC50) of extract for PBMC growth ranged between 0.8 and 3.1 mg/ml. Depending on the cell type used, therapeutic indices ranged between 200 and 6000. The extract inactivated HIV-1 infectivity directly when preincubated with virus before addition to human T-cell lines. Fractionation of the extract revealed antiviral activity in the polysaccharide fraction and also in a fraction depleted of polysaccharides and tannins. We conclude that aqueous A platensis extracts contain antiretroviral activity that may be of potential clinical interest.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593452     DOI: 10.1097/00042560-199805010-00002

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  22 in total

1.  Protective effect of Spirulina against 4-nitroquinoline-1-oxide induced toxicity.

Authors:  Vijaya Padma Viswanadha; Siddharth Sivan; Roopesh Rajendra Shenoi
Journal:  Mol Biol Rep       Date:  2010-03-30       Impact factor: 2.316

2.  The Inhibitory Effect of C-phycocyanin Containing Protein Extract (C-PC Extract) on Human Matrix Metalloproteinases (MMP-2 and MMP-9) in Hepatocellular Cancer Cell Line (HepG2).

Authors:  Mugdha Kunte; Krutika Desai
Journal:  Protein J       Date:  2017-06       Impact factor: 2.371

3.  Induction of heme oxygenase-1 by phenylarsine oxide. Studies in cultured primary liver cells.

Authors:  O S Gildemeister; J A Pepe; R W Lambrecht; H L Bonkovsky
Journal:  Mol Cell Biochem       Date:  2001-10       Impact factor: 3.396

4.  Viral inhibitors derived from macroalgae, microalgae, and cyanobacteria: A review of antiviral potential throughout pathogenesis.

Authors:  Daman Reynolds; Michael Huesemann; Scott Edmundson; Amy Sims; Brett Hurst; Sherry Cady; Nathan Beirne; Jacob Freeman; Adam Berger; Song Gao
Journal:  Algal Res       Date:  2021-05-18       Impact factor: 4.401

5.  TOL19-001 reduces inflammation and MMP expression in monolayer cultures of tendon cells.

Authors:  Catherine Baugé; Sylvain Leclercq; Thierry Conrozier; Karim Boumediene
Journal:  BMC Complement Altern Med       Date:  2015-07-09       Impact factor: 3.659

6.  Impact of daily supplementation of Spirulina platensis on the immune system of naïve HIV-1 patients in Cameroon: a 12-months single blind, randomized, multicenter trial.

Authors:  Marthe-Elise Ngo-Matip; Constant Anatole Pieme; Marcel Azabji-Kenfack; Bruno Moukette Moukette; Emmanuel Korosky; Philippe Stefanini; Jeanne Yonkeu Ngogang; Carl Moses Mbofung
Journal:  Nutr J       Date:  2015-07-21       Impact factor: 3.271

7.  Enhancement of immune activation activities of Spirulina maxima grown in deep-sea water.

Authors:  Woon Yong Choi; Do Hyung Kang; Hyeon Yong Lee
Journal:  Int J Mol Sci       Date:  2013-06-06       Impact factor: 5.923

8.  Potential of Spirulina Platensis as a Nutritional Supplement in Malnourished HIV-Infected Adults in Sub-Saharan Africa: A Randomised, Single-Blind Study.

Authors:  M Azabji-Kenfack; S Edie Dikosso; E G Loni; E A Onana; E Sobngwi; E Gbaguidi; A L Ngougni Kana; G Nguefack-Tsague; D Von der Weid; O Njoya; J Ngogang
Journal:  Nutr Metab Insights       Date:  2011-05-02

9.  Spirulina in clinical practice: evidence-based human applications.

Authors:  P D Karkos; S C Leong; C D Karkos; N Sivaji; D A Assimakopoulos
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-19       Impact factor: 2.629

10.  Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report.

Authors:  Patricia V Torres-Duran; Aldo Ferreira-Hermosillo; Marco A Juarez-Oropeza
Journal:  Lipids Health Dis       Date:  2007-11-26       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.